Ironwood Pharmaceuti (IRWD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 146,907 | 106,584 | 120,295 | 174,422 | 141,562 |
| Marketable Securities | N/A | N/A | N/A | N/A | 19,836 |
| Receivables | 96,570 | 103,786 | 72,617 | 80,950 | 65,375 |
| Inventories | 2,298 | 1,735 | 593 | N/A | 76 |
| Other current assets | 0 | 0 | 0 | 847 | 0 |
| TOTAL | $257,638 | $220,985 | $201,832 | $266,435 | $248,548 |
| Non-Current Assets | |||||
| PPE Net | 11,381 | 6,665 | 19,017 | 7,652 | 16,161 |
| Intangibles | 785 | 785 | 785 | 785 | 785 |
| Other Non-Current Assets | 64,539 | 87,286 | 141,904 | 57,178 | 151,158 |
| TOTAL | $76,705 | $94,736 | $161,706 | $65,615 | $168,104 |
| Total Assets | $334,343 | $315,721 | $363,538 | $332,050 | $416,652 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 48,797 | 45,961 | 47,554 | 39,191 |
| Accounts payable and accrued liabilities | 6,098 | 9,908 | 11,203 | 14,891 | 9,332 |
| Accrued Expenses | 35,485 | 40,252 | 49,325 | 40,964 | 50,046 |
| Other current liabilities | N/A | N/A | N/A | 51 | 74 |
| TOTAL | $52,795 | $110,861 | $118,569 | $119,524 | $112,582 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 78,330 | 90,140 | 100,537 | 108,589 |
| Deferred Revenues | 1,278 | N/A | N/A | 252 | 13,768 |
| Other Non-Current Liabilities | 434,595 | 345,897 | 392,008 | 301,894 | 386,663 |
| TOTAL | $434,595 | $424,227 | $482,148 | $408,897 | $501,365 |
| Total Liabilities | $487,390 | $535,088 | $600,717 | $528,421 | $613,947 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 156,818 | 156,496 | 155,621 | 154,645 | 154,059 |
| Common Shares | 157 | 156 | 156 | 154 | 154 |
| Retained earnings | -1,620,090 | -1,640,738 | -1,650,412 | -1,591,128 | -1,575,635 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | -9 |
| TOTAL | $-153,047 | $-219,367 | $-237,179 | $-196,371 | $-197,295 |
| Total Liabilities And Equity | $334,343 | $315,721 | $363,538 | $332,050 | $416,652 |